About Innova Formulations Private Limited
Data last updated:
Innova Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U60231DL2005PTC132986.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Rx Logistics Private Limited. It is led by directors Aditya Jagdishmitter Gupta and Shelly Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot At Kh No. 1020 G/F Front Side Portion Village Mundra, Extn, New Delhi, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.41 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹1,513 (net margin -0.4%) and EBITDA of -₹2,046 (EBITDA margin -0.6%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The company is associated with 1 brand: Innova Formulations.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovapharma.in.
Company details
Contact details
Innova Formulations Private Limited's registered office is in New Delhi, Delhi. Its website is innovapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot At Kh No. 1020 G/F Front Side Portion Village Mundra, Extn, New Delhi, Delhi, India – 110041
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Innova Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Innova Formulations operates one associated brand: Innova Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medicines, supplements, and healthcare products in India. | innovaformulations.com |
Business activity
The main business activity of Innova Formulations is professional, scientific and technical. In detail, this covers advertising and market research.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M6 | Advertising and market research |
To see the full business activity and turnover split of Innova Formulations Private Limited, buy the company report.
Financials of Innova Formulations Private Limited
FY 2025 filings availableInnova Formulations Private Limited reported revenue of ₹3.41 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 8% fall in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2,046 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,513 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innova Formulations Private Limited, buy the company report.
Board of directors of Innova Formulations Private Limited
Innova Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Jagdishmitter Gupta Also directs: RX Healthcare Limited, RX Biotech Private Limited, Rhone Poulenc Labs Private Limited and 1 more | Director | 14 Feb 2005 | 21 Years 8 Months | Current |
| Shelly Gupta Also directs: RX Healthcare Limited, RX Biotech Private Limited, Rhone Poulenc Labs Private Limited and 1 more | Director | 15 Feb 2007 | 19 Years 8 Months | Current |
Auditor
Innova Formulations Private Limited is audited by SARDA SONI ASSOCIATES LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARDA SONI ASSOCIATES LLP | FY 2020 | 117235W |
Shareholding
The shareholding of Innova Formulations Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Innova Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innova Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innova Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Innova Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Innova Formulations Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Shelly Gupta was appointed as Director on 15 Feb 2007.
Frequently asked questions
Innova Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2005 (21+ years old) and is registered under CIN U60231DL2005PTC132986.
Innova Formulations has 2 current directors:
- Aditya Jagdishmitter Gupta - Director
- Shelly Gupta - Director
The latest financial statements of Innova Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Innova Formulations is U60231DL2005PTC132986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innova Formulations was incorporated on 14 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Shelly Gupta was appointed as Director on 15 Feb 2007. Aditya Jagdishmitter Gupta was appointed as Director on 14 Feb 2005.
Innova Formulations can be reached through the website innovapharma.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Innova Formulations is at Plot At Kh No. 1020 GF Front Side Portion Village Mundra, Extn, New Delhi, Delhi, India – 110041.
Innova Formulations operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Innova Formulations is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.